Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada. Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives.
For more than 100 years, the development of our products has been based on Merz`s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer’s disease research. Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.
Globally, Merz has a long successful heritage in aesthetics, dating back to the days when company founder Friedrich Merz studied the effects of rejuvenating essences on the skin. In 1953, the company presented the first anti-wrinkle preparation in Paris, France, creating a cosmetic sensation. Renowned for exceptional quality and outstanding results, the Merz Aesthetics product portfolio is trusted by both patients and expert medical aesthetics practitioners around the world.
We have a proven ability to discover what physicians need, and we work with them to achieve desired results for patients throughout the US. As a result, Merz Aesthetics has built a strong portfolio of innovative products and services in the US.